| Prevention of Post-operative Pneumonia (POPP) (NCT01446874) | Washington University School of Medicine | 2011-09-22 |
| Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer (NCT01787006) | University Hospital Schleswig-Holstein | 2011-09-01 |
| Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients (NCT01766349) | Far Eastern Memorial Hospital | 2011-09-01 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (NCT01929720) | Ohio State University Comprehensive Cancer Center | 2011-08-01 |
| PLA for HCC and Esophageal ca Serum (NCT01957241) | National Taiwan University Hospital | 2011-08-01 |
| A Survivorship Care Plan for Gynaecological Cancer Patients (NCT01582906) | Royal Marsden NHS Foundation Trust | 2011-08-01 |
| PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy (NCT01333033) | Alliance for Clinical Trials in Oncology | 2011-07-01 |
| Validation of a Nutrition Screening Tool (NCT01851928) | Royal Marsden NHS Foundation Trust | 2011-07-01 |
| Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders (NCT01438385) | Weill Medical College of Cornell University | 2011-07-01 |
| Optimal Management of Malignant Dysphagia (NCT01366833) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-06-01 |
| Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer (NCT01386346) | Weill Medical College of Cornell University | 2011-06-01 |
| Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial (NCT01463605) | Chinese Academy of Medical Sciences | 2011-06-01 |
| CHFR Methylation Status Esophageal Cancer Study (NCT01372202) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-06-01 |
| Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer (NCT01471249) | Centre hospitalier de l'Université de Montréal (CHUM) | 2011-06-01 |
| Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus (NCT01348217) | Centre Georges Francois Leclerc | 2011-05-06 |
| Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients (NCT01368419) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2011-05-01 |
| Health-related Quality of Life of Patients With Esophageal Cancer After Surgery (NCT01349517) | Fudan University | 2011-05-01 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer (NCT01246960) | Eli Lilly and Company | 2011-04-01 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer (NCT02209415) | Michael Bau Mortensen | 2011-04-01 |
| Fecal Screening Assay for Taiwanese Population (NCT01341197) | National Taiwan University Hospital | 2011-03-01 |
| CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer (NCT01191697) | Dana-Farber Cancer Institute | 2011-02-01 |
| Esophageal Cancer Tissue Banking (NCT01780961) | Washington University School of Medicine | 2011-01-25 |
| Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy (NCT01242124) | Tianjin Medical University Cancer Institute and Hospital | 2011-01-01 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas (NCT01143545) | National Cancer Institute (NCI) | 2010-12-07 |
| Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium (NCT01293448) | Pentax Medical | 2010-12-01 |
| Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01291823) | Zhejiang Cancer Hospital | 2010-12-01 |
| Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas (NCT01258868) | National Cancer Institute (NCI) | 2010-12-01 |
| Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus (NCT01301495) | Weill Medical College of Cornell University | 2010-11-01 |
| Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer (NCT03066167) | Vastra Gotaland Region | 2010-11-01 |
| Perception Prognosis, Goals of Treatment, and Communication (NCT01401894) | Massachusetts General Hospital | 2010-10-01 |
| Trimodality Management of T1b Esophageal Cancers (NCT01217060) | M.D. Anderson Cancer Center | 2010-10-01 |
| Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. (NCT02166320) | Karolinska University Hospital | 2010-10-01 |
| Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer (NCT01216813) | Royal Marsden NHS Foundation Trust | 2010-08-01 |
| Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position (NCT01144325) | Fudan University | 2010-07-01 |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery (NCT01107639) | Swiss Cancer Institute | 2010-05-27 |
| Morbidity in Open Versus Minimally Invasive Esophagectomy (NCT03035071) | Austrian Society Of Surgical Oncology | 2010-05-01 |
| Simultaneous Integrated Boost (SIB) in Esophageal Cancer (NCT01102088) | M.D. Anderson Cancer Center | 2010-04-01 |
| Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) (NCT01267578) | University of Yamanashi | 2010-04-01 |
| A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer (NCT01051479) | Wake Forest University Health Sciences | 2010-03-01 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) (NCT01077817) | Organon and Co | 2010-02-26 |
| S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01175447) | Zhejiang Cancer Hospital | 2010-02-01 |
| Quality of Life With Esophageal Stent Trial (NCT01044511) | Michael Bau Mortensen | 2010-01-01 |
| The Effect of Nutritional Counseling for Cancer Patients (NCT01962272) | University of Copenhagen | 2010-01-01 |
| Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00938470) | Alliance for Clinical Trials in Oncology | 2010-01-01 |
| S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer (NCT01175460) | Zhejiang Cancer Hospital | 2010-01-01 |
| Chemoradiation and Panitumumab for Esophageal Cancer (NCT01077999) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-01-01 |
| Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches (NCT01053182) | Sichuan University | 2010-01-01 |
| Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology (NCT03462524) | St. James's Hospital, Ireland | 2010-01-01 |
| Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer (NCT03061370) | St. James's Hospital, Ireland | 2010-01-01 |
| Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer (NCT01038544) | Centre hospitalier de l'Université de Montréal (CHUM) | 2009-12-01 |
| a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent (NCT01054274) | Southeast University, China | 2009-12-01 |
| Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer (NCT01038154) | Hospital Donostia | 2009-11-01 |
| Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer (NCT01003808) | ImmunoFrontier, Inc. | 2009-11-01 |
| Open Versus Laparoscopically-assisted Esophagectomy for Cancer (NCT00937456) | University Hospital, Lille | 2009-10-07 |
| IMRT/Pemetrexed/Cisplatin in Esophageal Cancer (NCT01630174) | Shandong Cancer Hospital and Institute | 2009-10-01 |
| Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer (NCT00985192) | Translational Oncology Research International | 2009-09-01 |
| Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction (NCT00891878) | Alliance for Clinical Trials in Oncology | 2009-08-01 |
| Cologne Esophageal Response Prediction Study (CERP-Study) (NCT00953511) | Elfriede Bollschweiler | 2009-08-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer (NCT00911820) | Dana-Farber Cancer Institute | 2009-07-01 |
| Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer (NCT00917462) | Memorial Sloan Kettering Cancer Center | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| European iNvestigation of SUrveillance After Resection for Esophageal Cancer (NCT03461341) | St. James's Hospital, Ireland | 2009-06-01 |
| Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus (NCT00903136) | US Department of Veterans Affairs | 2009-05-01 |
| CryoSpray Ablation (TM) GI Patient Registry (NCT00747448) | CSA Medical, Inc. | 2009-05-01 |
| Phase II Study of Irinotecan and Panitumumab (NCT00836277) | Weijing Sun, MD, FACP | 2009-05-01 |
| Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer (NCT01836913) | University Medical Center Groningen | 2009-05-01 |
| A Study of Patients Receiving High-Dose Rate Brachytherapy (NCT00924027) | National Cancer Institute (NCI) | 2009-04-14 |
| Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer (NCT00160875) | University Health Network, Toronto | 2009-04-01 |
| Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus (NCT00987857) | Gloucestershire Hospitals NHS Foundation Trust | 2009-03-01 |
| Comparison of Standard of Care or Treatment on Protocol (NCT01010334) | New Mexico Cancer Research Alliance | 2009-03-01 |
| Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy (NCT01243398) | University of Oxford | 2009-03-01 |
| PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide (NCT00867477) | M.D. Anderson Cancer Center | 2009-03-01 |
| Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation (NCT00839605) | University of Missouri-Columbia | 2009-03-01 |
| Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors (NCT01043016) | Fujian Longhua Pharmaceutical Co. Ltd | 2009-03-01 |
| A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer (NCT00735826) | Dartmouth-Hitchcock Medical Center | 2009-03-01 |
| Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study (NCT00686465) | Ontario Clinical Oncology Group (OCOG) | 2009-03-01 |
| Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus. (NCT00754468) | CSA Medical, Inc. | 2009-02-01 |
| Sorafenib. ICORG 06-41, V4 (NCT01158287) | Cancer Trials Ireland | 2009-02-01 |
| AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer (NCT00719550) | Amgen | 2009-02-01 |
| Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin (NCT00831571) | Dana-Farber Cancer Institute | 2009-02-01 |
| FDG-PET-CT and Biomarkers in Esophageal Cancer (NCT00833625) | M.D. Anderson Cancer Center | 2009-02-01 |
| Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma (NCT00815308) | Shandong Cancer Hospital and Institute | 2009-01-01 |
| Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction (NCT00757172) | Alliance for Clinical Trials in Oncology | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study (NCT06165094) | Sichuan Cancer Hospital and Research Institute | 2009-01-01 |
| A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer (NCT01249352) | Eurofarma Laboratorios S.A. | 2009-01-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Quality of Life After Esophagectomy for Cancer (NCT00798746) | M.D. Anderson Cancer Center | 2008-11-01 |
| A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer (NCT00995358) | University of Yamanashi | 2008-11-01 |
| Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00551759) | Eastern Cooperative Oncology Group | 2008-10-02 |
| Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00732745) | Case Comprehensive Cancer Center | 2008-10-01 |
| Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer (NCT01034189) | National Taiwan University Hospital | 2008-10-01 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer (NCT00865982) | Charite University, Berlin, Germany | 2008-09-01 |
| Sutent + Taxol for Advanced Esophageal Cancer (NCT00730353) | Hoosier Cancer Research Network | 2008-08-01 |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma (NCT00737438) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Permission to Collect Blood Over Time for Research (NCT00767234) | Stanford University | 2008-08-01 |